Percutaneous kyphoplasty for the treatment of distal lumbosacral pain caused by osteoporotic thoracolumbar vertebral fracture

2018 ◽  
Vol 59 (11) ◽  
pp. 1351-1357 ◽  
Author(s):  
Junjie Niu ◽  
Dawei Song ◽  
Minfeng Gan ◽  
Bin Liu ◽  
Chenglong Tan ◽  
...  
Keyword(s):  
Back Pain ◽  
Vertebral Fracture ◽  
Therapeutic Efficacy ◽  
Analogue Scale ◽  
Therapeutic Benefit ◽  
Osteoporotic Vertebral Fracture ◽  
Kyphotic Angle ◽  
Degree Of Satisfaction ◽  
Thoracolumbar Vertebral Fracture

Background Kyphoplasty has been demonstrated to be minimally invasive and effective in treating osteoporotic vertebral fracture patients with back pain over the level of the fractured vertebrae. Rare studies have reported on thoracolumbar vertebral fracture patients presenting with distal lumbosacral pain (DLP). Whether kyphoplasty had a favorable therapeutic benefit for these patients remains unclear. Purpose To evaluate the therapeutic efficacy of kyphoplasty in treating osteoporotic thoracolumbar vertebral fracture (OTVF) patients with DLP and assess the clinical significance of focal tenderness to palpation in these patients. Material and Methods Thirty-two OTVF patients who only complained of DLP were treated by kyphoplasty. The vertebral heights, local kyphotic angle, Visual Analogue Scale (VAS), and Oswestry Disability Index (ODI) scores were assessed preoperatively, one day after surgery, and at last follow-up. All patients were evaluated regarding their degree of satisfaction with kyphoplasty. In addition, we compared the therapeutic efficacy of kyphoplasty in patients with and without focal tenderness to palpation. Results All patients successfully underwent kyphoplasty without complications. The vertebral heights, local kyphotic angles, VAS, and ODI scores were all significantly improved after kyphoplasty and maintained at last follow-up in our patients ( P < 0.001). At last follow-up, all patients expressed satisfaction with kyphoplasty. No significant differences in these parameters were detected between patients with and without focal tenderness. Conclusion The possibility of thoracolumbar vertebral fractures in elderly patients complaining of DLP should not be neglected. Kyphoplasty presents a superior benefit in treating OTVF patients with DLP. The absence of focal tenderness does not influence the clinical efficacy in these patients.

scholarly journals Effects of Mobilization Time on Occurrence of New Fractures after Vertebroplasty

2019 ◽  
Vol 2019 ◽  
pp. 1-5
Author(s):  
Ahmet Onur Akpolat ◽  
Sinan Karaca
Keyword(s):  
Risk Factor ◽  
Vertebral Fracture ◽  
Local Anesthesia ◽  
Postoperative Period ◽  
Statistical Difference ◽  
Treatment Options ◽  
Fracture Treatment ◽  
Osteoporotic Vertebral Fracture ◽  
The Mean

Introduction. Osteoporotic vertebral fracture treatment options include vertebroplasty, in which development of new fractures is among the possible complications which may develop during the postoperative period. We aim to evaluate whether or not postoperative mobilization time has effect on occurrence of new fractures. Materials and Methods. A total of 126 patients, consisting of 30 (39.7%) males and 96 (60.3%) females, who underwent sedation-assisted vertebroplasty under local anesthesia between January 2014 and June 2017 were retrospectively evaluated. Preoperative and postoperative visual analogue scores (VASs) and mobilization time (hours) were assessed. Day of new fracture occurrence during follow-up was assessed. Results. The mean follow-up period was 9 months (7–13 months). The most common fracture segment was the L1 vertebra (15.9%). The preoperative VAS was 8.29 ± 0.95, and the postoperative VAS was 2.33 ± 0.91. The change in VAS was statistically significant (p=0.01, p<0.05). Of all the patients, 21 (16.66%) had developed new fractures. No statistical difference was observed between mobilization time (hours) and formation of new fractures (p=0.48, p>0.05). Conclusion. We came to the conclusion that mobilization time (hours) was not a risk factor in the development of new fractures. In addition, there is no relationship between mobilization time and localization of new fractures.

scholarly journals Nonsurgical Corrective Union of Osteoporotic Vertebral Fracture with Once-Weekly Teriparatide

2015 ◽  
Vol 2015 ◽  
pp. 1-3
Author(s):  
Naohisa Miyakoshi ◽  
Akira Horikawa ◽  
Yoichi Shimada
Keyword(s):  
Vertebral Fracture ◽  
Fracture Healing ◽  
Clinical Experience ◽  
Vertebral Body ◽  
Vertebral Fractures ◽  
Surgical Intervention ◽  
Osteoporotic Vertebral Fracture ◽  
Kyphosis Angle ◽  
Osteoporotic Vertebral Fractures

Osteoporotic vertebral fractures usually heal with kyphotic deformities with subsidence of the vertebral body when treated conservatively. Corrective vertebral union using only antiosteoporotic pharmacotherapy without surgical intervention has not been reported previously. An 81-year-old female with osteoporosis presented with symptomatic fresh L1 vertebral fracture with intravertebral cleft. Segmental vertebral kyphosis angle (VKA) at L1 was 20° at diagnosis. Once-weekly teriparatide administration, hospitalized rest, and application of a thoracolumbosacral orthosis alleviated symptoms within 2 months. Corrective union of the affected vertebra was obtained with these treatments. VKA at 2 months after injury was 8° (correction, 12°) and was maintained as of the latest follow-up at 7 months. Teriparatide has potent bone-forming effects and has thus been expected to enhance fracture healing. Based on the clinical experience of this case, teriparatide may have the potential to allow correction of unstable vertebral fractures without surgical intervention.

Risk factor analysis for persistent back pain of intravertebral vacuum cleft after osteoporotic vertebral fracture

2013 ◽  
Vol 24 (4) ◽  
pp. 414-419 ◽  
Author(s):  
Kaoru Suseki ◽  
Yuzuru Takahashi ◽  
Tomoaki Toyone ◽  
Masashi Kito ◽  
Masaomi Yamashita ◽  
...  
Keyword(s):  
Factor Analysis ◽  
Risk Factor ◽  
Back Pain ◽  
Vertebral Fracture ◽  
Risk Factor Analysis ◽  
Osteoporotic Vertebral Fracture ◽  
Persistent Back Pain

scholarly journals Parathyroid Hormone Injection Versus Vertebroplasty in the Treatment of Osteoporotic Vertebral Fracture in Old Age: A Retrospective Study of 58 Female Patients

2020 ◽  
Author(s):  
Incheol Kook ◽  
Byeong-Jik Kang ◽  
Ye-Soo Park
Keyword(s):  
Parathyroid Hormone ◽  
Retrospective Study ◽  
Vertebral Fracture ◽  
Conservative Treatment ◽  
Vertebral Fractures ◽  
Cement Leakage ◽  
Osteoporotic Vertebral Fracture ◽  
Group I ◽  
Osteoporotic Vertebral Fractures

Abstract Background: While the indications of parathyroid hormone (PTH) in osteoporosis prevention and management have been established, its indications in the treatment of osteoporotic vertebral fractures remain unknown. This study aimed to compare the effects of intervention (percutaneous vertebroplasty followed by anti-resorptive agents) and conservative treatment (PTH administration) in patients with osteoporotic vertebral fractures, as well as to investigate the optimal duration of PTH administration. Methods: A retrospective study was conducted using data of patients treated for osteoporotic vertebral fractures between January 2015 and November 2019. Treatment was selected based on the patient’s age, comorbidities, and patient’s preference after explaining the expected advantages and disadvantages of each treatment. Group C was administered PTH injections once weekly, whereas Group I underwent vertebroplasty followed by the administration of anti-resorptive agents. Radiological and clinical parameters were analyzed between two groups.Results: This study enrolled 58 patients (77 vertebrae). Group C included 24 patients (38 vertebrae) with average age of 77.50 ± 7.19 years (range, 65–85 years), average bone mineral density (BMD) of −3.39 ± 0.86 (range, −2.5 to −5.8), average follow-up period of 27.47 ± 7.60 weeks (range, 12–49 weeks). Group I included 34 patients (39 vertebrae) with an average age of 76.20 ± 8.67 years (range, 65–92 years), average BMD of −3.35 ± 0.91 (range, −2.5 to −5.1), average follow-up period of 30.82 ± 10.95 weeks (range, 16–59 weeks). There was no significant difference between the two groups in initial demographic, clinical and radiographic parameters. Group I showed significantly better clinical and radiological outcome during the last follow-up. Regarding side effects in Group C, two cases of dizziness (8.3%), nausea and vomiting (8.3%) were reported. In Group I, cement leakage was found in 26 vertebrae (66.7%), and cement leakage complications were observed in four patients (11.8%). Conclusion: Conservative treatment using PTH injection demonstrated slower pain relief and lesser suppression of vertebral height loss than vertebroplasty. However, PTH injection demonstrated a lower risk of procedure-related complications. The patient’s age, preference, and general condition with respect to the procedure’s risk should be considered when determining treatment options for osteoporotic vertebral fracture in old age.

Is Bone Nonunion, Vertebral Deformity, or Spinopelvic Malalignment the Best Therapeutic Target for Amelioration of Low Back Pain After Osteoporotic Vertebral Fracture?

Spine ◽  
2020 ◽  
Vol 45 (13) ◽  
pp. E760-E767
Author(s):  
Akira Iwata ◽  
Masahiro Kanayama ◽  
Fumihiro Oha ◽  
Yukitoshi Shimamura ◽  
Tomoyuki Hashimoto ◽  
...  
Keyword(s):  
Low Back Pain ◽  
Back Pain ◽  
Vertebral Fracture ◽  
Therapeutic Target ◽  
Vertebral Deformity ◽  
Osteoporotic Vertebral Fracture ◽  
Low Back ◽  
Bone Nonunion

scholarly journals Underreporting characteristics of osteoporotic vertebral fracture in back pain clinic patients of a tertiary hospital in China

2020 ◽  
Vol 23 ◽  
pp. 152-158 ◽  
Author(s):  
Mei-Mei Du ◽  
Nazmi Che-Nordin ◽  
Pei-Pei Ye ◽  
Shi-Wen Qiu ◽  
Zhi-Han Yan ◽  
...  
Keyword(s):  
Back Pain ◽  
Vertebral Fracture ◽  
Tertiary Hospital ◽  
Pain Clinic ◽  
Osteoporotic Vertebral Fracture

scholarly journals Factors affecting neurological deficits and intractable back pain in patients with insufficient bone union following osteoporotic vertebral fracture

2009 ◽  
Vol 18 (9) ◽  
pp. 1279-1286 ◽  
Author(s):  
Masatoshi Hoshino ◽  
Hiroaki Nakamura ◽  
Hidetomi Terai ◽  
Tadao Tsujio ◽  
Masaharu Nabeta ◽  
...  
Keyword(s):  
Back Pain ◽  
Vertebral Fracture ◽  
Bone Union ◽  
Neurological Deficits ◽  
Osteoporotic Vertebral Fracture ◽  
Factors Affecting

scholarly journals Osteoporotic vertebral fracture misdiagnosed as “normal postoperative phenomenon” in post decompression surgery: a case report

2021 ◽  
Vol 22 (1) ◽  
Author(s):  
Li-sheng Hou ◽  
Dong Zhang ◽  
Feng Ge ◽  
Hai-feng Li ◽  
Tian-jun Gao
Keyword(s):  
Back Pain ◽  
Vertebral Fracture ◽  
Lower Back Pain ◽  
Early Stage ◽  
Decompression Surgery ◽  
Spinal Diseases ◽  
Osteoporotic Vertebral Fracture ◽  
Early Recovery ◽  
Lower Back ◽  
First Case

Abstract Background Previous research and published literature indicate that some patients with spinal diseases who underwent percutaneous transforaminal endoscopic decompression (PTED) still suffer some discomfort in the early recovery stage in the form of pain, stiffness, and swelling. These are usually considered minor residual symptoms or normal postoperative phenomenon (NPF) in the clinic, occur frequently, and are acknowledged by surgeons worldwide. To the best of our knowledge, we report the first case of a patient who had an osteoporotic vertebral fracture (OVF) misdiagnosed as NPF after she underwent PTED as a result of lumbar disc herniation (LDH). Case presentation A 71-year-old female with Parkinson’s disease who presented with lower back pain radiating to the legs was diagnosed as LDH in L4–5, after which a PTED of L4–5 was performed, with temporary alleviation of symptoms. However, severe lower back pain recurred. Unfortunately, the recurred pain initially misdiagnosed as NPF, in fact, was finally confirmed to be OVF by CT-scan. OVF in the early stage of post-PTED seldom occurs and is rarely reported in the literature. With a percutaneous vertebroplasty, the pain was significantly relieved, and she resumed walking. After 36-weeks of follow-up, the pain improved satisfactorily. Conclusion Doctors should not immediately diagnose a relapse of back pain following PTED as NPF, and hands-on careful physical and imaging examinations are necessary to manage recurring pain rightly and timely.

scholarly journals Presence of sarcopenia does not affect the clinical results of balloon kyphoplasty for acute osteoporotic vertebral fracture

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Shoichiro Ohyama ◽  
Masatoshi Hoshino ◽  
Shinji Takahashi ◽  
Yusuke Hori ◽  
Hiroyuki Yasuda ◽  
...  
Keyword(s):  
Back Pain ◽  
Vertebral Fracture ◽  
Vertebral Deformity ◽  
Short Form ◽  
Balloon Kyphoplasty ◽  
Clinical Results ◽  
Osteoporotic Vertebral Fracture ◽  
Mineral Density ◽  
Hand Grip ◽  
Sf 36

AbstractSarcopenia has been associated with poor clinical outcomes in several diseases. Herein, the clinical results of balloon kyphoplasty (BKP) for acute osteoporotic vertebral fracture (OVF) treatment were assessed and compared between sarcopenia and non-sarcopenia patients. Sixty patients who underwent BKP for treatment of acute OVF with poor prognostic factors between April 2016 and September 2017 and were assessed for sarcopenia were enrolled. Clinical results (back pain on visual analogue scale [VAS]; short-form [SF] 36; vertebral deformity; activities of daily living levels; and incidence of adjacent vertebral fractures) were compared between the two groups at 6 months post-BKP. Data analysis revealed that back pain on VAS, SF-36 scores, and vertebral deformity improved from baseline to 6 months after BKP. Thirty-nine patients (65.0%) were diagnosed with sarcopenia and demonstrated a lower body mass index (21.2 vs. 23.3 kg/m2, p = 0.02), skeletal muscle mass index (5.32 vs. 6.55 kg/m2, p < 0.01), hand-grip strength (14.7 vs. 19.2 kg, p = 0.01), and bone mineral density of the femoral neck (0.57 vs. 0.76 g/cm2, p < 0.01) than those of patients without sarcopenia. However, no significant differences were observed in the clinical results between these groups. Therefore, BKP’s clinical results for the treatment of acute OVF are not associated with sarcopenia.

Sign in / Sign up

Export Citation Format

Share Document